Madeleine M. Grigg-Damberger

Madeleine Grigg-Damberger practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Madeleine Grigg-Damberger's NPI, 1760497218, was assigned on July 30, 2006. Madeleine Grigg-Damberger graduated from Loyola University of Chicago, Stritch School of Medicine in 1978. Madeleine Grigg-Damberger holds New Mexico license 97-66.

Madeleine Grigg-Damberger's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Madeleine Grigg-Damberger's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Madeleine Grigg-Damberger to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Madeleine Grigg-Damberger practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Madeleine Grigg-Damberger's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Madeleine Grigg-Damberger is licensed in New Mexico.

CMS data shows 123 Medicare services from Madeleine Grigg-Damberger across 3 procedure codes in 2024, for 117 Medicare patients. Medicare paid $18,531 for them.

CMS counts 117 Medicare patients who saw Madeleine Grigg-Damberger in 2024. The largest group is 75 to 84, with 41 patients. 73% of them have high blood pressure, and 72% have high cholesterol. 41% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Madeleine Grigg-Damberger's median patient age at 53, with 53% women.

In 2024, Madeleine Grigg-Damberger wrote 17 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $271 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Madeleine Grigg-Damberger for performance year 2024, reported as part of a group. Madeleine Grigg-Damberger accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 34 papers to Madeleine Grigg-Damberger, published from 2011 to 2025. 2022 was the busiest year, with 8. The most frequent topics are Sleep, Polysomnography and Sleep Apnea, Obstructive. Madeleine Grigg-Damberger has published most often in J Clin Sleep Med. Madeleine Grigg-Damberger's most frequent co-authors are Nancy R. Foldvary-Schaefer, DO, Lisa Cutchen and Sasikanth Gorantla, MD.

CMS Open Payments shows 6 general payments to Madeleine Grigg-Damberger from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Jazz Pharmaceuticals Inc. paid the most, $124.

Madeleine Grigg-Damberger graduated from Loyola University of Chicago, Stritch School of Medicine in 1978.